Takeda Pharmaceutical
TAK
#454
Rank
$43.05 B
Marketcap
$13.36
Share price
-0.96%
Change (1 day)
-12.96%
Change (1 year)

Takeda Pharmaceutical (TAK) - Cash on Hand

Cash on Hand as of March 2024 : $3.12 B

According to Takeda Pharmaceutical's latest financial reports the company has $3.12 B in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Takeda Pharmaceutical - Cash on Hand chart (from 2008 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-03-31$4.15 B-42.03%
2022-03-31$7.17 B-21.12%
2021-03-31$9.09 B50.31%
2020-03-31$6.04 B-7.45%
2019-03-31$6.53 B85.19%
2018-03-31$3.52 B4.87%
2017-03-31$3.36 B-32.48%
2016-03-31$4.98 B-16.16%
2015-03-31$5.94 B-28.13%
2014-03-31$8.27 B38.81%
2013-03-31$5.95 B7.23%
2012-03-31$5.55 B-47.14%
2011-03-31$10.51 B11.33%
2010-03-31$9.44 B23.18%
2009-03-31$7.66 B-54.57%
2008-03-31$16.87 B10.41%
2007-03-31$15.28 B-3.72%
2006-03-31$15.87 B11.75%
2005-03-31$14.20 B12.35%
2004-03-31$12.64 B30.74%
2003-03-31$9.67 B45.49%
2002-03-31$6.64 B16.37%
2001-03-31$5.71 B

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
$26.21 B 739.38%๐Ÿ‡บ๐Ÿ‡ธ USA
$9.92 B 217.86%๐Ÿ‡ซ๐Ÿ‡ท France
$11.92 B 281.91%๐Ÿ‡บ๐Ÿ‡ธ USA
$9.69 B 210.36%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
$1.23 B-60.40%๐Ÿ‡บ๐Ÿ‡ธ USA
$0.97 B-68.71%๐Ÿ‡ฎ๐Ÿ‡ณ India
$9.70 B 210.81%๐Ÿ‡บ๐Ÿ‡ธ USA
$5.17 B 65.68%๐Ÿ‡ฌ๐Ÿ‡ง UK
$5.61 B 79.90%๐Ÿ‡บ๐Ÿ‡ธ USA